Varied prevalence of factor V G1691A (Leiden) and prothrombin G20210A single nucleotide polymorphisms among Arabs

Journal of Thrombosis and Thrombolysis

Volumn 20, Issue 3, 2005, Pages 163-168

  Almawi, Wassim Y ^a,b   Keleshian, Sose H ^b   Borgi, Lobna ^c   Fawaz, Naglaa A ^d   Abboud, Nisreen ^c   Mtiraoui, Nabil ^c   Mahjoub, Touhami ^c  

^a ARABIAN GULF UNIVERSITY   (Bahrain)

^b HAIGAZIAN UNIVERSITY   (Lebanon)

^c UNIVERSITY OF MONASTIR   (Tunisia)

^d IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

APC resistance; Factor V Leiden; PCR; Prothrombin G20210A mutation

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN;

ARAB; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC HETEROGENEITY; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HETEROZYGOSITY; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; VENOUS THROMBOEMBOLISM;

ALLELES; ARABS; FACTOR V; GENE FREQUENCY; HUMANS; MIDDLE EAST; POINT MUTATION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROTHROMBIN; RISK FACTORS; THROMBOEMBOLISM; TUNISIA;

EID: 27944450847     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-005-3550-4     Document Type: Article

References (33)

1. Rosendaal FR. Venous thrombosis: A multicausal disease. Lancet 1999;353:1167-1173. 10.1016/S0140-6736(98)10266-0
2. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-67. 10.1038/369064a0
3. Rees DC, Chapman NH, Webster MT, Guerreiro JF, Rochette J, Clegg JB. Born to clot: The European burden. Br J Haematol. 1999;105:564-566. 10233439
4. Hira B, Pegoraro RJ, Rom L, Moodley J. Absence of Factor V Leiden, thrombomodulin and prothrombin gene variants in Black South African women with pre-eclampsia and eclampsia. BJOG. 2003;110:327-328. 12628278
5. Abdulkadir J, Feleke Y, Berg JP, Falch JA, Odegaard OR. Absence of the factor V Leiden mutation in Ethiopians. Thromb Res. 1997;86:181-182. 10.1016/S0049-3848(97)00061-3
6. Arnutti P, Nathalang O, Cowawintaweewat S, Prayoonwiwat W, Choovichian P. Factor V Leiden and prothrombin G20210A mutations in Thai patients awaiting kidney transplant. Southeast Asian J Trop Med Public Health. 2002;33:869-871. 12757241
7. Kim TW, Kim WK, Lee JH, et al. Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep venous thrombosis. J Korean Med Sci. 1998;13:587-590. 9886165
8. Lu Y, Zhao Y, Liu G, et al. Factor V gene G1691A mutation, prothrombin gene G20210A mutation, and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population. Thromb Res. 2002;106:7-12. 10.1016/S0049-3848(02)00064-6
9. Irani-Hakime N, Tamim H, Kreidy R, Almawi WY. The prevalence of factor V R506Q mutation-Leiden among apparently healthy Lebanese. Am J Hematol. 2000;65:45-49. 10.1002/ 1096-8652(200009)65:1<45::AID-AJH8>3.0.CO;2-V
10. Tamim H, Finan RR, Almawi, WY. Prevalence of two thrombophilia predisposing mutations: Factor V G1691A (R506Q; Leiden) and prothrombin G20210A, among healthy Lebanese. Thromb Haemost. 2002;88:691-692. 12362248
11. Batioglu F, Atmaca LS, Karabulut HG, Beyza Sayin D. Factor V Leiden and prothrombin gene G20210A mutations in ocular Behcet disease. Acta Ophthalmol Scand. 2003;81:283-285. 10.1034/j.1600-0420.2003.00068.x
12. Angelopoulou K, Nicolaides A, Constantinou Deltas C. Prevalence of genetic mutations that predispose to thrombophilia in a Greek Cypriot population. Clin Appl Thromb Hemost. 2000;6:104-107. 10775032
13. Atherosclerosis, Thrombosis, and Vascular Biology Italian Study Group. No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation. 2003;107:1117-1122.
14. Lopaciuk S, Bykowska K, Kwiecinski H, et al. Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke. Clin Appl Thromb Hemost. 2001;7:346-350. 11697722
15. Coen D, Zadro R, Honovic L, Banfic L, Stavljenic Rukavina A. Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism. Croat Med J. 2001;42:488-492. 11471205
16. Aznar J, Vaya A, Estelles A, et al. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives. Haematologica. 2000;85:1271-1276. 11114134
17. Zivelin A, Griffin JH, Xu X, et al. A single genetic origin for a common Caucasian risk factor for venous thrombosis. Blood. 1997;89:397-402. 9002940
18. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood. 1996;88:3698-3703. 8916933
19. Dahlbäck B. Resistance to activated protein C as risk factor for thrombosis; molecular mechanism, laboratory investigation and clinical management. Sem Haematol. 1997;34:217-34.
20. Emmerich J, Rosendaal FR, Cattaneo M, et al. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism - pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism. Thromb Haemost. 2001;86:809-816. 11583312
21. Eid SS, Rihani G. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians. Clin Lab Sci. 2004;17:200-202. 15559724
22. Mathonnet F, Nadifi S, Serazin-Leroy V, Dakouane M, Giudicelli Y. Absence of factor V Leiden mutation and low prothrombin G 20210 A mutation prevalence in a healthy Moroccan population. Thromb Haemost. 2002;88:1073-1074. 12529766
23. Chafa O, Reghis A, Aubert A, Fischer AM. Prevalence of the FVQ506 (factor V Leiden) mutation in the normal and thrombophilic Algerian population. Br J Haematol. 1997;97:688-689. 9207426
24. Awidi A, Shannak M, Bseiso A, et al. High prevalence of factor V Leiden in healthy Jordanian Arabs. Thromb Haemost. 1999;81:582-584. 10235443
25. Rosen E, Renbaum P, Heyd J, Levy-Lahad E. High frequency of factor V Leiden in a population of Israeli Arabs. Thromb Haemost. 1999;82:1768. 10613668
26. Castoldi E, Lunghi B, Mingozzi F, Ioannou P, Marchetti G, Bernardi F. New coagulation factor V gene polymorphisms define a single and infrequent haplotype underlying the factor V Leiden mutation in Mediterranean populations and Indians. Thromb Haemost. 1997;78:1037-1041. 9308750
27. Sanchez-Mazas A, Butler-Brunner E, Excoffier L, et al. New data for AG haplotype frequencies in Caucasoid populations and selective neutrality of the AG polymorphism. Hum Biol. 1994;66:27-48. 8157263
28. Dilley A, Austin H, Hooper WC, et al. Relation of three genetic traits to venous thrombosis in an African-American population. Am J Epidemiol. 1998;147:30-35. 9440395
29. Hessner MJ, Luhm RA, Pearson SL, Endean DJ, Friedman KD, Montgomery RR. Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylene-tetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR. Thromb Haemost. 1999;81:733-738. 10365746
30. de Maat MP, Kluft C, Jespersen J, Gram J. World distribution of factor V Leiden mutation. Lancet. 1996;347:58. 10.1016/S0140-6736(96)91590-1
31. Garewal G, Das R, Ahluwalia J, Mittal N, Varma S. Prothrombin G20210A is not prevalent in North India. J Thromb Haemost. 2003;1:2253-2254. 10.1046/j.1538-7836.2003.00430.x
32. Finan RR, Tamim H, Ameen G, Sharida HE, Rashid M, Almawi WY. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population. Am J Hematol. 2002;71:300-305. 10.1002/ajh.10223
33. Mtiraoui N, Borgi L, Hizem S, et al. Prevalence of antiphospholipid antibodies, factor V G1691A (Leiden) and prothrombin G20210A mutations in first and second trimester recurrent pregnancy loss. Eur J Obstet Gynecol Reprod Biol. 2005;119:164-170. 10.1016/j.ejogrb.2004.07.003